Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

11.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.7K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

160
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
160
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

6.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

8.8K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
8.8K
The Inner Mitochondrial Membrane01:28

The Inner Mitochondrial Membrane

3.8K
The inner mitochondrial membrane is the primary site of ATP synthesis. The inner membrane domain that forms a smooth layer adjacent to the outer membrane is called the inner boundary membrane. This domain contains membrane transporters that drive metabolites in and out of the mitochondria.  In contrast, the inner membrane network that invaginates into the matrix space is called the cristae membrane. This domain accounts for principle mitochondrial function as it accommodates the protein...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent Advances in Diagnostic Strategies and Nanotechnology-Based Therapies for Ovarian Cancer Treatment.

ACS applied bio materials·2025
Same author

Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer.

Cancer immunology, immunotherapy : CII·2025
Same author

A Synthetic Nanoparticle to Mimic High-Density Lipoprotein for Reverse Cholesterol Transport.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Magnetoelectric Extracellular Vesicle Latency-Targeting (MELT) Nanotherapeutic for the Block-Lock-and-Kill HIV Eradication Strategy.

Biomedicines·2025
Same author

Recent advances in nanogels for drug delivery and biomedical applications.

Biomaterials science·2024
Same author

Cell specific mitochondria targeted metabolic alteration for precision medicine.

Nanoscale·2024

Related Experiment Video

Updated: Apr 21, 2026

Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges
06:50

Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges

Published on: October 4, 2024

1.6K

Targeted nanoparticles in mitochondrial medicine.

Rakesh K Pathak1, Nagesh Kolishetti, Shanta Dhar

  • 1NanoTherapeutics Research Laboratory, Department of Chemistry, University of Georgia, Athens, GA, USA.

Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|October 29, 2014
PubMed
Summary

Biodegradable nanoparticles offer a promising solution for delivering therapeutics to mitochondria, addressing challenges in mitochondrial medicine and disease treatment. These advanced platforms enhance drug delivery for various conditions.

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.2K
Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

11.8K

Related Experiment Videos

Last Updated: Apr 21, 2026

Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges
06:50

Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges

Published on: October 4, 2024

1.6K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.2K
Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

11.8K

Area of Science:

  • Biomedical Engineering
  • Cell Biology
  • Nanotechnology

Background:

  • Mitochondria are crucial for cellular energy production and mortality regulation.
  • Mitochondrial dysfunction is implicated in diseases like cancer, atherosclerosis, and neurodegenerative disorders.
  • Targeting mitochondria presents a therapeutic strategy for related diseases, but faces challenges due to mitochondrial complexity.

Purpose of the Study:

  • To review advancements in biodegradable nanoparticle platforms for mitochondrial targeting.
  • To explore the potential of nanomaterials in developing hybrid nanomedical platforms for mitochondria.
  • To highlight effective drug delivery tools for mitochondrial medicine.

Main Methods:

  • Review of current literature on nanoparticle-based mitochondrial targeting.
  • Analysis of nanomaterials including metal oxides, gold nanoparticles, dendrons, carbon nanotubes, and liposomes.
  • Focus on biodegradable polymeric nanoparticles for drug delivery.

Main Results:

  • Nanomaterials offer unique properties (biodegradability, magnetization, fluorescence) for nanomedical platforms.
  • Existing nanoparticles (metal oxides, gold, etc.) face in vivo biocompatibility challenges.
  • Biodegradable polymeric nanoparticles show promise as effective drug delivery systems.

Conclusions:

  • Biodegradable nanoparticles are emerging as key tools for mitochondrial medicine.
  • These platforms can overcome limitations of existing mitochondrial targeting strategies.
  • Further development of these nanoparticles holds potential for treating mitochondrial dysfunction-related diseases.